treatment

Why is lung cancer so difficult to treat?

Posted by  | treatment

“When we think about lung cancer, we usually think of it being associated with people who smoke,” says Russell K. Hales, M.D. “But, in fact, non-smoking associated lung cancer is common as well”.  In fact, if non-smoking associated lung cancer were its own category, it would rank in the top ten for cancer related death(...)

Our Story of Cancer: Alleviate the Suffering of Patients with Cancer

Posted by  | treatment

We've asked our staff to share their thoughts on the PBS documentary, Cancer: Emperor of All Maladies. This week, we'll post their comments, including how they hope it will influence the public dialogue on cancer, research and treatment. Ephraim Fuchs, M.D., M.B.A., professor of oncology and immunology at the Johns Hopkins Kimmel Cancer Center shares his thoughts:(...)

Our Story of Cancer: Further Gains in Preventing, Treating and Curing Cancer in the Near Future

Posted by  | Prevention/Screening, Research, treatment

We've asked our staff to share their thoughts on the PBS documentary, Cancer: Emperor of All Maladies. This week, we'll post their comments, including how they hope it will influence the public dialogue on cancer, research and treatment. Terry Langbaum, MHS, Chief Administrative Officer at the Johns Hopkins Kimmel Cancer Center, shares her thoughts: We are hoping(...)

Immunotherapy drug approved for lung cancer

Posted by  | treatment

There is good news today for lung cancer patients. The FDA has announced that it has approved expansion of the immunotherapy drug nivolumab (Opdivo) for certain lung cancer patients. Julie Brahmer, M.D., oncologist at the Johns Hopkins Kimmel Cancer Center and director of its Thoracic Oncology Program, is one of the leaders of the initial,(...)

Promise & Progress in Radiation Oncology

Posted by  | treatment

The latest issue of the Kimmel Cancer Center’s magazine Promise & Progress marks the 10th anniversary of the Department of Radiation Oncology and Molecular Radiation Sciences.  Knifeless radiosurgery, proton beams, radiation sensitizing drugs, immune-stimulating therapies, informatics systems, efficiencies models, and inventions that move research forward and make treatments safer are a sampling of the exciting(...)

Meeting the Needs of Metastatic Cancer Patients

Posted by  | treatment

*This post was written by Marie Borsellino, B.S.N., R.N., O.C.N., oncology nurse navigator for the Managing Cancer at Work Program As we close international breast cancer awareness month, I would like to honor those women and finally the organizations that support those living with metastatic breast cancer. We know that in 2013, an estimated 232,340 new cases(...)

9 Issues Clinicians Are Talking About in Breast Cancer Care

Posted by  | treatment

**Note: This blog was written by Elissa Bantug of the Kimmel Cancer Center's Breast Cancer Program. On March 7-8, 2013, over two hundred physicians, nurses, and other healthcare providers from around the region attended the Seventh Bi-Annual Johns Hopkins Breast Cancer Conference to discuss the latest trends in research and clinical care.  Due to improved(...)

Hormone Therapy Combined with Chemotherapy Increases Survival for Prostate Cancer Patients

Posted by  | treatment

Early results from a study funded by the National Institutes of Health (NIH) have shown that men with hormone-sensitive metastatic prostate cancer who have received a combination of the chemotherapy drug docetaxel and hormone therapy lived longer than patients who received hormone therapy alone. The study enrolled 790 men with metastatic prostate cancer who received(...)